EarningsAfya reported solid results with medical courses tickets increasing 5% YoY, Adj EBITDA margin expanding 290bp YoY and adj. net income up by 29% YoY.
Growth StrategyAfya's growth could be supported by inorganic expansion, approval of potential medical seats, and continuing education and medical practice solution expansion.
Market PositioningAfya is well positioned in the premium medicine market.